bNovate Technologies SA logo — Rapid and automated online bacteria monitoring in drinking w...

bNovate Technologies SA

Rapid and automated online bacteria monitoring in drinking water for SAFE WATER. ANYTIME. ANYWHERE.

Founded 2011 Switzerland Ecublens, Switzerland 42 employees Series C Total: $17.18M Automation, Biotechnology +3

General Information

Company Name bNovate Technologies SA
Founded Year 2011
Location Switzerland Ecublens, Switzerland
Employees 42
Industries Automation, Biotechnology, Hardware +2
Funding Stage Series C
Business Model B2B, D2C, SaaS
Revenue Model Product Sales, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with bNovate Technologies SA. To contact bNovate Technologies SA, visit bnovate.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does bNovate Technologies SA compare?

A PDF of bNovate Technologies SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting bNovate Technologies SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About bNovate Technologies SA

bNovate Technologies SA, founded in 2011 and headquartered in Switzerland, is carving a niche in the rapid and automated bacteria monitoring landscape. Its slogan, "SAFE WATER. ANYTIME. ANYWHERE.," underscores its commitment to enhancing water safety through innovation.

Specializing in industries such as Automation, Biotechnology, Hardware, Industrial, and Information Technology, bNovate Technologies offers groundbreaking solutions with its proprietary industrial flow cytometry technology. This technology reduces microbiology result times from days to just 20 minutes, catering to the needs of both pharmaceutical and drinking water sectors.

The company recently closed a Series C investment of Fr.12.00M, led by Emerald Technology Ventures on 20 June 2023. This investment signals strong confidence in their growth trajectory and technological potential, making bNovate Technologies SA a compelling proposition for investors seeking opportunities in water safety and technological innovation.

Business keywords: Rapid Microbiological Monitoring, Automated Flow Cytometry, Drinking Water Safety, Industrial Flow Cytometry Technology, Microbiological Analysis Instruments, Water Analysis, Cell Detection Instruments, Flow Cytometer Development, Water Treatment, Pharmaceutical Water Monitoring, Total Cell Count, Online Bacteria Monitoring, Innovative Water Safety Solutions, Scientific Expertise in Water Monitoring

Services & Products

Real-time microbial monitoring
Automated online flow cytometry solutions
Rapid microbiology testing
Data-driven water safety assurance

Target Customers

Drinking water suppliers Bottled water manufacturers Pharmaceutical companies Cosmetic manufacturers Research institutions Universities

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Fr.12.00M 1
Emerald Technology Ventures
20 Jun 2023
Grant Fr.175.00K 1
HCL Technologies
18 Jan 2023
Series B Fr.5.00M 2
Celeste Management, Ronald Strässler
07 May 2021
Grant Undisclosed 1
Eurostars
19 Mar 2019

bNovate Technologies SA Alternatives & Competitors

bNovate Technologies SA vs

AI + Light for Microbiology

Series A
70 employees
Industrial, Information Technology
bNovate Technologies SA vs

The experts in AI technology for drug discovery and development.

Series C
182 employees
AI, Analytics

FAQ About bNovate Technologies SA

Rapid and automated online bacteria monitoring in drinking water for SAFE WATER. ANYTIME. ANYWHERE.
bNovate Technologies SA was founded in 2011.
bNovate Technologies SA is headquartered in Ecublens, Switzerland.
bNovate Technologies SA operates in Automation, Biotechnology, Hardware, Industrial and Information Technology. Its work centres on Rapid Microbiological Monitoring, Automated Flow Cytometry, Drinking Water Safety and Industrial Flow Cytometry Technology. Its customers include Drinking water suppliers, Bottled water manufacturers and Pharmaceutical companies.
bNovate Technologies SA has a B2B, D2C and SaaS business model. Its revenue comes from Product Sales, Service Fee and Subscription.
bNovate Technologies SA has approximately 42 employees.
bNovate Technologies SA has completed 4 funding rounds, raising a total of $17.18M. The latest funding stage is Series C.
bNovate Technologies SA offers: Real-time microbial monitoring, Automated online flow cytometry solutions, Rapid microbiology testing, Data-driven water safety assurance.
Top alternatives and competitors to bNovate Technologies SA include Spore.Bio, Partex.AI Technology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
bNovate Technologies SA and Spore.Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for bNovate Technologies SA, https://bouncewatch.com/company/bnovate-technologies-sa, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes